PDF(Pubmed)
Abstract：
The development of an international, precompetitive, collaborative, ultraviolet (UV) research consortium is discussed as an opportunity to lay the groundwork for a new UV commercial industry and the supply chain to support this industry. History has demonstrated that consortia can offer promising approaches to solve many common, current industry challenges, such as the paucity of data regarding the doses of ultraviolet-C (UV-C, 200 nm to 280 nm) radiation necessary to achieve the desired reductions in healthcare pathogens and the ability of mobile disinfection devices to deliver adequate doses to the different types of surfaces in a whole-room environment. Standard methods for testing are only in the initial stages of development, making it difficult to choose a specific UV-C device for a healthcare application. Currently, the public interest in UV-C disinfection applications is elevated due to the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the respiratory coronavirus disease 19 (COVID-19). By channeling the expertise of different UV industry stakeholder sectors into a unified international consortium, innovation in UV measurements and data could be developed to support test methods and standards development for UV healthcare equipment. As discussed in this paper, several successful examples of consortia are applicable to the UV industry to help solve these types of common problems. It is anticipated that a consortium for the industry could lead to UV applications for disinfection becoming globally prolific and commonplace in residential, work, business, and school settings as well as in transportation (bus, rail, air, ship) environments. Aggressive elimination of infectious agents by UV-C technologies would also help to reduce the evolution of antibiotic-resistant bacteria.
摘要：
国际的发展，竞争前,协作,讨论了紫外线（UV）研究联盟，作为为新的UV商业行业和支持该行业的供应链奠定基础的机会。历史表明，财团可以提供有希望的方法来解决许多常见的，当前行业挑战，例如关于紫外线-C(UV-C，200nm至280nm）辐射，以实现所需的医疗保健病原体减少以及移动消毒设备在整个房间环境中向不同类型的表面提供足够剂量的能力。标准测试方法仅在开发的初始阶段，这使得很难为医疗保健应用选择特定的UV-C设备。目前,由于严重急性呼吸道综合症冠状病毒2（SARS-CoV-2）的传播，公众对UV-C消毒应用的兴趣提高了，导致呼吸道冠状病毒病19（COVID-19）的病毒。通过将不同紫外线行业利益相关者部门的专业知识引入一个统一的国际财团，可以开发紫外线测量和数据方面的创新，以支持紫外线医疗设备的测试方法和标准开发。正如本文所讨论的，联盟的几个成功的例子适用于UV行业，以帮助解决这些类型的常见问题。预计该行业的财团可能会导致紫外线消毒应用在全球住宅中变得多产和司空见惯，工作,business,和学校设置以及交通(公共汽车，rail,空气,船舶)环境。通过UV-C技术积极消除感染因子也将有助于减少抗生素抗性细菌的进化。
